Sulfonylureas target the neurovascular response to decrease Alzheimer's pathology

SL Macauley, MS Stanley, EE Caesar, WR Moritz… - bioRxiv, 2021 - biorxiv.org
… Neuronal release of amyloid-β (Aβ) and tau, the pathological … investigated K ATP channel
expression in the temporal cortex in … For example, diazoxide, a K ATP channel agonist, …

NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease

M Amani, M Zolghadrnasab, AA Salari - Physiology & behavior, 2019 - Elsevier
… ) channels in animal models of AD [59,60]. Given that K ATP channels are implicated in
AD … -801 treatment in the hippocampus improved learning and memory abilities in STZ-treated …

Selective secretase targeting for Alzheimer's disease therapy

A Miranda, E Montiel, H Ulrich… - … of Alzheimer's Disease, 2021 - content.iospress.com
… : amyloid-β (Aβ) in plaques and phosphorylated tau in … Recently, ligustilide has shown
to ameliorate memory and … AβPPβ, suggesting that diazoxide inhibited amyloidogenic …

Brain regional synchronous activity predicts tauopathy in 3× TgAD mice

D Liu, H Lu, E Stein, Z Zhou, Y Yang, MP Mattson - Neurobiology of aging, 2018 - Elsevier
Alzheimer's disease (AD) is characterized by progressive … amyloid β-peptide (Aβ) plaques
and intraneuronal tau … Our findings reveal that, at least in the 3×TgAD mouse model, …

Identification of potential repurposable drugs in alzheimer's disease exploiting a bioinformatics analysis

G Fiscon, P Sibilio, A Funari, F Conte… - Journal of personalized …, 2022 - mdpi.com
… to prevent or restore memory deficit, as observed in a mouse model of AD [… reduce Amyloid
β and tau pathologies in mice [48]. … -sensitive potassium channel opener, diazoxide has been …

Levosimendan ameliorates the scopolamine induced cognitive impairment via modulating pCREB/BDNF expression, cholinergic neurotransmission and …

AS Kolusu, GS Ganesh, M Nagabhairava… - 2023 - researchsquare.com
… via activation of BACE-1 enzyme, Amyloid-β accumulation, … Alzheimer’s-like
scopolamine-induced amnesic mice model. … Pathologies and Improves Memory in the 3xTgAD

Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs

GM Jojo, G Kuppusamy, K Selvaraj… - … & Metabolic Disorders, 2019 - Springer
murine model of leptin-resistant obese mice amelioratedamelioration of Aβ and tau pathology
along with memory enhancement upon treatment with KATP channel activator-diazoxide […

Inhibition of β-amyloid channels with a drug candidate wgx-50 revealed by molecular dynamics simulations

S Hou, RX Gu, DQ Wei - … of chemical information and modeling, 2017 - ACS Publications
… (37) Additionally, diazoxide, a potassium ATP channel activator, was reported to improve
memory … in the cortex and hippocampus in a mouse model with AD in in vivo experiments by …

Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures

N Chopra, FP Perez, B Maloney, JJ Morisaki, DK Lahiri - 2021 - scholarship.depauw.edu
… The KATP channel activator diazoxide ameliorates amyloid-β and Tau pathologies and
improves memory in the 3xTgAD mouse model of Alzheimer’s disease. J. …

… , safety and efficacy of the use of intravenous infusions of adenosine triphosphate (atp) in people affected by moderate to severe alzheimer's disease: A double-blind …

A Ruiz, D Sánchez, A Lafuente, G Ortega… - … of Alzheimer's Disease, 2022 - Springer
… protein precursor, being the characteristic amyloid-β plaques … in AD mice models with the
KATP agonist diazoxide suggest that … of KATP channels also decreased the memory disorders, …